Novozymes A/S (OTCMKTS:NVZMY) Shares Cross Below 200-Day Moving Average - Should You Sell?

Shares of Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $61.33 and traded as low as $57.54. Novozymes A/S shares last traded at $58.31, with a volume of 9,634 shares traded.

Analysts Set New Price Targets

Separately, Barclays upgraded Novozymes A/S to a "strong-buy" rating in a report on Monday, November 18th.

Novozymes A/S Stock Performance

The company's 50-day moving average price is $57.21 and its 200 day moving average price is $61.24. The stock has a market capitalization of $28.28 billion, a PE ratio of 38.22, a PEG ratio of 3.87 and a beta of 0.91.

Novozymes A/S Increases Dividend

The company also recently declared a dividend, which will be paid on Wednesday, April 23rd. Investors of record on Monday, April 7th will be given a dividend of $0.3758 per share. The ex-dividend date of this dividend is Monday, April 7th. This is a positive change from Novozymes A/S's previous dividend of $0.17. Novozymes A/S's payout ratio is currently 94.94%.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.